| Medical and Health Sciences | 2021-2025 | 810 | US 283 | 99.82 |
| Internal Medicine | Lifetime | 88 | US 30 | 98.07 |
| Hematology | Lifetime | 344 | US 168 | 97.99 |
| Internal Medicine | 2021-2025 | 11 | US 5 | 98.66 |
| Hematology | 2021-2025 | 80 | US 43 | 98.27 |
| Surgery | 2021-2025 | 532 | US 207 | 95.64 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 356 | US 167 | 96.09 |
| Immunology | 2021-2025 | 665 | US 238 | 79.88 |
| Intramuscular injections and effects | Lifetime | 8 | US 3 | 98.76 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 275 | US 114 | 99.16 |
| Platelet Disorders and Treatments | Lifetime | 167 | US 64 | 98.70 |
| Blood groups and transfusion | Lifetime | 164 | US 70 | 98.52 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 50 | US 21 | 98.56 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 504 | US 214 | 98.76 |
| Autoimmune Bullous Skin Diseases | Lifetime | 378 | US 127 | 97.30 |
| COVID-19 and healthcare impacts | Lifetime | 711 | US 251 | 93.26 |
| Blood Coagulation and Thrombosis Mechanisms | Lifetime | 687 | US 254 | 96.34 |
| Hemophilia Treatment and Research | Lifetime | 302 | US 115 | 96.34 |
| Case Reports on Hematomas | Lifetime | 109 | US 38 | 93.22 |
| Complement system in diseases | Lifetime | 923 | US 344 | 93.43 |
| Hemostasis and retained surgical items | Lifetime | 584 | US 220 | 82.06 |
| Venous Thromboembolism Diagnosis and Management | 2021-2025 | 37 | US 14 | 99.36 |
| Platelet Disorders and Treatments | 2021-2025 | 12 | US 3 | 99.01 |
| Blood groups and transfusion | 2021-2025 | 15 | US 4 | 98.87 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 15 | US 3 | 97.10 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 242 | US 70 | 98.20 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 185 | US 59 | 96.29 |
| Intramuscular injections and effects | 2021-2025 | 10 | US 1 | 94.29 |
| Complement system in diseases | 2021-2025 | 90 | US 27 | 94.61 |
| COVID-19 and healthcare impacts | 2021-2025 | 765 | US 262 | 90.56 |
| Blood Coagulation and Thrombosis Mechanisms | 2021-2025 | 124 | US 32 | 91.41 |
| Clinical practice guidelines implementation | 2021-2025 | 170 | US 32 | 87.67 |
| Hemophilia Treatment and Research | 2021-2025 | 124 | US 33 | 93.41 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 839 | US 166 | 84.33 |
| Case Reports on Hematomas | 2021-2025 | 73 | US 23 | 77.93 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 889 | US 168 | 77.67 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 850 | US 188 | 72.74 |
| Hemostasis and retained surgical items | 2021-2025 | 881 | US 104 | 25.17 |
